Showing results (241-250 of 372) with videos related to

Sort By:
Pageof 38
Diabetes|July 30, 2002
Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levelsMarju Orho-Melander, Mia Klannemark, Malin K Svensson, et al.
Endocrine Connections|April 8, 2025
Estimation of kidney function in Graves' disease using creatinine and cystatin CSorena Abbaszadeh, Martin H Lundqvist, Östen Ljunggren, et al.
Advances in Therapy|September 15, 2025
Disease Progression, Clinical Outcomes and Treatment Challenges in Patients with Chronic Kidney Disease and High-Risk ProteinuriaRoberto Pecoits-Filho, Johan Bodegård, Phil Ambery, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 1, 1996
Design of an ultrasonic therapy system for breast cancer treatmentX Q Lu, E C Burdette, B A Bornstein, et al.
Pulmonary Pharmacology & Therapeutics|March 27, 2003
Health-related quality of life in asthma studies. Can we combine data from different countries?E Ståhl, D S Postma, E F Juniper, et al.
Journal of Medicinal Chemistry|April 1, 1987
Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonistsA M Johansson, L E Arvidsson, U Hacksell, et al.
The Journal of Hospital Infection|October 12, 2025
Correlation of airborne bacteria in the operating room with surgical wound contamination and surgical site infection: a systematic reviewJ Seth Caous, K Svensson Malchau, C Björn, et al.
Journal of Medicinal Chemistry|October 1, 1990
Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralinA M Johansson, K Fredriksson, U Hacksell, et al.
Toxicology and Applied Pharmacology|April 11, 2006
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblastsPayal Bhaiya, Sanjoy Roychowdhury, Piyush M Vyas, et al.
Journal of Diabetes and Its Complications|December 19, 2012
Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes populationHanri Afghahi, Mervete Miftaraj, Ann-Marie Svensson, et al.
Pageof 38